ODTX
Odyssey Therapeutics, Inc.
18.10$
+0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| – | +9.3% | -50.0% | -100.0% | – | |
| – | +23.2% | -22.0% | +6.9% | +12.1% | |
| – | +7.5% | +66.2% | -44.4% | +43.0% | |
| – | +20.2% | -7.0% | -8.4% | +39.4% | |
| – | – | – | – | – | |
| – | -50.0% | +0.0% | +400.0% | +100.0% | |
| – | – | – | – | – | |
| – | – | – | – | -112.7% | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.